drugset

drugset / Trial / NCT07575230

Suzetrigine vs Norco-postoperative Mohs Pain

NCT07575230 ↗

Phase 4 Enrolling by invitation 75 enrolled Baylor Research Institute

RandomizedParallel-groupOpen-labelTreatment

Summary

To compare suzetrigine versus hydrocodone/acetaminophen for postoperative pain control following dermatologic surgery.

Timeline

Start: 2025-11-03
Primary completion: 2027-12
Completion: 2027-12

Publications

Background Ad Hoc Task Force; Connolly SM, Baker DR, Coldiron BM, Fazio MJ, Storrs PA, Vidimos AT, Zalla MJ, Brewer JD, Smith Begolka W; Ratings Panel; Berger TG, Bigby M, Bolognia JL, Brodland DG, Collins S, Cronin TA Jr, Dahl MV, Grant-Kels JM, Hanke CW, Hruza GJ, James WD, Lober CW, McBurney EI, Norton SA, Roenigk RK, Wheeland RG, Wisco OJ. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol. 2012 Oct;67(4):531-50. doi: 10.1016/j.jaad.2012.06.009. Epub 2012 Sep 5.
Background Phillips, Shay, et al.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Acetaminophen	Small molecule	325 mg	—
Comparator	Hydrocodone	Unknown	5 mg	—
Comparator	Suzetrigine	Small molecule	—	—

Indications